Stimulants
Stimulants are compounds that increase activity in the nervous system, leading to heightened alertness, energy, and concentration. These compounds are used to treat conditions such as ADHD, narcolepsy, and fatigue. Research in this area focuses on understanding the mechanisms of action, therapeutic effects, and potential side effects of stimulants. At CymitQuimica, we offer a range of stimulant compounds for research purposes, supporting studies in neuroscience and pharmacology.
Products of "Stimulants"
Sort by
Phenylacetone Drug Precursor
CAS:Controlled ProductFormula:C9H10OColor and Shape:NeatMolecular weight:134.18Rolicyclidine Hydrochloride
CAS:Controlled ProductApplications An analog of the hallucinogen Phencyclidine (P295500). References Maddox, V.H., et al.: J. Med. Chem., 8, 230 (1965),Formula:C16H23N·ClHColor and Shape:NeatMolecular weight:265.82Benzeneacetic acid, a-(hydroxymethyl)-(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, sulfate (2:1) (salt),monohydrate
CAS:Formula:C17H27NO8SPurity:98.5%Color and Shape:SolidMolecular weight:405.46324-Phenyl-2-oxopyrrolidine-1-acetamide
CAS:Formula:C12H14N2O2Purity:99.58%Color and Shape:SolidMolecular weight:218.25184-(N-Methyl-N-nitrosamino)-4-(3-pyridyl)butanal
CAS:Controlled ProductApplications A tobacco smoke-derived nitrosamine which is activated by multiple human cytochrome P 450s including the polymorphic human cytochrome P 4502D6. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Castonguay, A., et al.: Cancer Lett., 46, 93 (1989), Crespi, C.L., et al.: Carcinogenesis, 12, 1197 (1991),Formula:C10H13N3O2Color and Shape:Light Brown LiquidMolecular weight:207.231,7-Bis-(5-oxohexyl)-3-methylxanthine
CAS:Controlled ProductFormula:C18H26N4O4Color and Shape:NeatMolecular weight:362.42(R)-Modafinil-d10
CAS:Controlled ProductApplications Labelled (R)-Modafinil. Used for treatment of excessive sleepiness, α1-adrenoceptor agonist. References Saletu, B., et al.: Int. J. Clin. Pharmacol. Res., 9, 183 (1989), Chemelli, R.M., et al.: Cell, 98, 437 (1999), Purnell, M., et al.: J. Sleep Res., 11, 219 (2002), Dinges, D., et al.: Curr. Med. Res. Opin., 22, 159 (2006)Formula:C15D10H5NO2SColor and Shape:NeatMolecular weight:283.41DL-threo-Ritalinic Acid-d10 (Major)
CAS:Controlled ProductFormula:C13H7D10NO2Color and Shape:NeatMolecular weight:229.34Theobromine
CAS:Controlled ProductApplications A metabolite of Caffeine. References Suto, M., et al.: Anticancer Drug Des., 6, 107 (1991), Burkart, V., et al.: Nat. Med., 5, 314 (1999), Hassa, P., et al.: J. Biol. Chem., 278, 45145 2003), Veres, B., et al.: J. Pharmacol. Exp. Ther., 310, 247(2004),Formula:C7H8N4O2Color and Shape:WhiteMolecular weight:180.162,4-DIAMINO-5-PHENYLTHIAZOLE MONOHYDROBROMIDE
CAS:Formula:C9H10BrN3SPurity:98%Color and Shape:SolidMolecular weight:272.1648
![Benzeneacetic acid, a-(hydroxymethyl)-(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, sulfate…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00IAI7.webp&w=3840&q=75)
